IBDEI3GV ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58306,2)
;;=^5005295
;;^UTILITY(U,$J,358.3,58307,0)
;;=H53.40^^272^2906^78
;;^UTILITY(U,$J,358.3,58307,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58307,1,3,0)
;;=3^Visual Field Defects,Unspec
;;^UTILITY(U,$J,358.3,58307,1,4,0)
;;=4^H53.40
;;^UTILITY(U,$J,358.3,58307,2)
;;=^5006324
;;^UTILITY(U,$J,358.3,58308,0)
;;=H01.001^^272^2906^8
;;^UTILITY(U,$J,358.3,58308,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58308,1,3,0)
;;=3^Blepharitis,Right Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58308,1,4,0)
;;=4^H01.001
;;^UTILITY(U,$J,358.3,58308,2)
;;=^5004238
;;^UTILITY(U,$J,358.3,58309,0)
;;=H01.002^^272^2906^7
;;^UTILITY(U,$J,358.3,58309,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58309,1,3,0)
;;=3^Blepharitis,Right Lower Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58309,1,4,0)
;;=4^H01.002
;;^UTILITY(U,$J,358.3,58309,2)
;;=^5004239
;;^UTILITY(U,$J,358.3,58310,0)
;;=H25.13^^272^2906^10
;;^UTILITY(U,$J,358.3,58310,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58310,1,3,0)
;;=3^Cataract,Age-Related Nuclear,Bilateral
;;^UTILITY(U,$J,358.3,58310,1,4,0)
;;=4^H25.13
;;^UTILITY(U,$J,358.3,58310,2)
;;=^5005286
;;^UTILITY(U,$J,358.3,58311,0)
;;=H25.12^^272^2906^11
;;^UTILITY(U,$J,358.3,58311,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58311,1,3,0)
;;=3^Cataract,Age-Related Nuclear,Left Eye
;;^UTILITY(U,$J,358.3,58311,1,4,0)
;;=4^H25.12
;;^UTILITY(U,$J,358.3,58311,2)
;;=^5005285
;;^UTILITY(U,$J,358.3,58312,0)
;;=H25.11^^272^2906^12
;;^UTILITY(U,$J,358.3,58312,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58312,1,3,0)
;;=3^Cataract,Age-Related Nuclear,Right Eye
;;^UTILITY(U,$J,358.3,58312,1,4,0)
;;=4^H25.11
;;^UTILITY(U,$J,358.3,58312,2)
;;=^5005284
;;^UTILITY(U,$J,358.3,58313,0)
;;=G45.3^^272^2906^1
;;^UTILITY(U,$J,358.3,58313,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58313,1,3,0)
;;=3^Amaurosis Fugax
;;^UTILITY(U,$J,358.3,58313,1,4,0)
;;=4^G45.3
;;^UTILITY(U,$J,358.3,58313,2)
;;=^304129
;;^UTILITY(U,$J,358.3,58314,0)
;;=D31.32^^272^2906^16
;;^UTILITY(U,$J,358.3,58314,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58314,1,3,0)
;;=3^Choroidal Nevus,Left Eye
;;^UTILITY(U,$J,358.3,58314,1,4,0)
;;=4^D31.32
;;^UTILITY(U,$J,358.3,58314,2)
;;=^5002122
;;^UTILITY(U,$J,358.3,58315,0)
;;=D31.31^^272^2906^17
;;^UTILITY(U,$J,358.3,58315,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58315,1,3,0)
;;=3^Choroidal Nevus,Right Eye
;;^UTILITY(U,$J,358.3,58315,1,4,0)
;;=4^D31.31
;;^UTILITY(U,$J,358.3,58315,2)
;;=^5002121
;;^UTILITY(U,$J,358.3,58316,0)
;;=H34.813^^272^2906^13
;;^UTILITY(U,$J,358.3,58316,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58316,1,3,0)
;;=3^Central Retinal Vein Occlusion,Bilateral
;;^UTILITY(U,$J,358.3,58316,1,4,0)
;;=4^H34.813
;;^UTILITY(U,$J,358.3,58316,2)
;;=^5005570
;;^UTILITY(U,$J,358.3,58317,0)
;;=H34.812^^272^2906^14
;;^UTILITY(U,$J,358.3,58317,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58317,1,3,0)
;;=3^Central Retinal Vein Occlusion,Left Eye
;;^UTILITY(U,$J,358.3,58317,1,4,0)
;;=4^H34.812
;;^UTILITY(U,$J,358.3,58317,2)
;;=^5005569
;;^UTILITY(U,$J,358.3,58318,0)
;;=H34.811^^272^2906^15
;;^UTILITY(U,$J,358.3,58318,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58318,1,3,0)
;;=3^Central Retinal Vein Occlusion,Right Eye
;;^UTILITY(U,$J,358.3,58318,1,4,0)
;;=4^H34.811
;;^UTILITY(U,$J,358.3,58318,2)
;;=^5005568
;;^UTILITY(U,$J,358.3,58319,0)
;;=E11.321^^272^2906^66
;;^UTILITY(U,$J,358.3,58319,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58319,1,3,0)
;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GV 3980 printed Sep 23, 2025@20:24:34 Page 2
IBDEI3GV ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58306,2)
+2 ;;=^5005295
+3 ;;^UTILITY(U,$J,358.3,58307,0)
+4 ;;=H53.40^^272^2906^78
+5 ;;^UTILITY(U,$J,358.3,58307,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,58307,1,3,0)
+8 ;;=3^Visual Field Defects,Unspec
+9 ;;^UTILITY(U,$J,358.3,58307,1,4,0)
+10 ;;=4^H53.40
+11 ;;^UTILITY(U,$J,358.3,58307,2)
+12 ;;=^5006324
+13 ;;^UTILITY(U,$J,358.3,58308,0)
+14 ;;=H01.001^^272^2906^8
+15 ;;^UTILITY(U,$J,358.3,58308,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,58308,1,3,0)
+18 ;;=3^Blepharitis,Right Upper Eyelid,Unspec
+19 ;;^UTILITY(U,$J,358.3,58308,1,4,0)
+20 ;;=4^H01.001
+21 ;;^UTILITY(U,$J,358.3,58308,2)
+22 ;;=^5004238
+23 ;;^UTILITY(U,$J,358.3,58309,0)
+24 ;;=H01.002^^272^2906^7
+25 ;;^UTILITY(U,$J,358.3,58309,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,58309,1,3,0)
+28 ;;=3^Blepharitis,Right Lower Eyelid,Unspec
+29 ;;^UTILITY(U,$J,358.3,58309,1,4,0)
+30 ;;=4^H01.002
+31 ;;^UTILITY(U,$J,358.3,58309,2)
+32 ;;=^5004239
+33 ;;^UTILITY(U,$J,358.3,58310,0)
+34 ;;=H25.13^^272^2906^10
+35 ;;^UTILITY(U,$J,358.3,58310,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,58310,1,3,0)
+38 ;;=3^Cataract,Age-Related Nuclear,Bilateral
+39 ;;^UTILITY(U,$J,358.3,58310,1,4,0)
+40 ;;=4^H25.13
+41 ;;^UTILITY(U,$J,358.3,58310,2)
+42 ;;=^5005286
+43 ;;^UTILITY(U,$J,358.3,58311,0)
+44 ;;=H25.12^^272^2906^11
+45 ;;^UTILITY(U,$J,358.3,58311,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,58311,1,3,0)
+48 ;;=3^Cataract,Age-Related Nuclear,Left Eye
+49 ;;^UTILITY(U,$J,358.3,58311,1,4,0)
+50 ;;=4^H25.12
+51 ;;^UTILITY(U,$J,358.3,58311,2)
+52 ;;=^5005285
+53 ;;^UTILITY(U,$J,358.3,58312,0)
+54 ;;=H25.11^^272^2906^12
+55 ;;^UTILITY(U,$J,358.3,58312,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,58312,1,3,0)
+58 ;;=3^Cataract,Age-Related Nuclear,Right Eye
+59 ;;^UTILITY(U,$J,358.3,58312,1,4,0)
+60 ;;=4^H25.11
+61 ;;^UTILITY(U,$J,358.3,58312,2)
+62 ;;=^5005284
+63 ;;^UTILITY(U,$J,358.3,58313,0)
+64 ;;=G45.3^^272^2906^1
+65 ;;^UTILITY(U,$J,358.3,58313,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,58313,1,3,0)
+68 ;;=3^Amaurosis Fugax
+69 ;;^UTILITY(U,$J,358.3,58313,1,4,0)
+70 ;;=4^G45.3
+71 ;;^UTILITY(U,$J,358.3,58313,2)
+72 ;;=^304129
+73 ;;^UTILITY(U,$J,358.3,58314,0)
+74 ;;=D31.32^^272^2906^16
+75 ;;^UTILITY(U,$J,358.3,58314,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,58314,1,3,0)
+78 ;;=3^Choroidal Nevus,Left Eye
+79 ;;^UTILITY(U,$J,358.3,58314,1,4,0)
+80 ;;=4^D31.32
+81 ;;^UTILITY(U,$J,358.3,58314,2)
+82 ;;=^5002122
+83 ;;^UTILITY(U,$J,358.3,58315,0)
+84 ;;=D31.31^^272^2906^17
+85 ;;^UTILITY(U,$J,358.3,58315,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,58315,1,3,0)
+88 ;;=3^Choroidal Nevus,Right Eye
+89 ;;^UTILITY(U,$J,358.3,58315,1,4,0)
+90 ;;=4^D31.31
+91 ;;^UTILITY(U,$J,358.3,58315,2)
+92 ;;=^5002121
+93 ;;^UTILITY(U,$J,358.3,58316,0)
+94 ;;=H34.813^^272^2906^13
+95 ;;^UTILITY(U,$J,358.3,58316,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,58316,1,3,0)
+98 ;;=3^Central Retinal Vein Occlusion,Bilateral
+99 ;;^UTILITY(U,$J,358.3,58316,1,4,0)
+100 ;;=4^H34.813
+101 ;;^UTILITY(U,$J,358.3,58316,2)
+102 ;;=^5005570
+103 ;;^UTILITY(U,$J,358.3,58317,0)
+104 ;;=H34.812^^272^2906^14
+105 ;;^UTILITY(U,$J,358.3,58317,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,58317,1,3,0)
+108 ;;=3^Central Retinal Vein Occlusion,Left Eye
+109 ;;^UTILITY(U,$J,358.3,58317,1,4,0)
+110 ;;=4^H34.812
+111 ;;^UTILITY(U,$J,358.3,58317,2)
+112 ;;=^5005569
+113 ;;^UTILITY(U,$J,358.3,58318,0)
+114 ;;=H34.811^^272^2906^15
+115 ;;^UTILITY(U,$J,358.3,58318,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,58318,1,3,0)
+118 ;;=3^Central Retinal Vein Occlusion,Right Eye
+119 ;;^UTILITY(U,$J,358.3,58318,1,4,0)
+120 ;;=4^H34.811
+121 ;;^UTILITY(U,$J,358.3,58318,2)
+122 ;;=^5005568
+123 ;;^UTILITY(U,$J,358.3,58319,0)
+124 ;;=E11.321^^272^2906^66
+125 ;;^UTILITY(U,$J,358.3,58319,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,58319,1,3,0)
+128 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
